Case Studies
Innovative Reformulation of a Complex, High-Drug-Load, Modified Release Dosage Form with Reduced Dosing Frequency
![Innovative Reformulation White Paper](https://www.societalcdmo.com/wp-content/uploads/2022/03/societal-cdmo_innovative-reformulation-of-a-complex-high-drug-load-modified-release-dosage-form-with-reduced-dosing-frequency_white-paper-e1652399424338.png)
The FDA wants you to reformulate your opioid oral controlled-release product to provide a level of abuse deterrence. A lengthy, expensive ordeal seems inevitable. But what if you could limit and position the formulation change as only a CMC prior approval supplement under the FDA’s scale-up and post-approval changes guidance? We helped a client in exactly this position accomplish a complex reformulation and successful CMC supplement filing in less than a year. Learn more by downloading this case study.